Close Menu

NEW YORK – Aethlon Medical announced on Thursday that a $3.5 million grant from the National Institute for Dental and Craniofacial Research (NIDCR) will support a collaborative project with University of Pittsburgh's Hillman Cancer Center to explore if its Hemopurifier device can deplete circulating exosomes and make head and neck cancer patients more responsive to treatments.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.